Intro

This chapter examines the fluctuating stock market in light of recent retail earnings and impending import tariffs announced by the president-elect. It also addresses the decline in Amgen's stock due to investor concerns despite positive developments in its obesity drug.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app